Target intelligence / Profile preview

RNA, U6 small nuclear 158, pseudogene (RNU6-158P)

Target
RNU6-158P
Molecular classification
Other, Non-coding RNA pseudogene
01

Overview

RNU6-158P (RNA, U6 small nuclear 158, pseudogene) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA itself is a highly conserved non-coding RNA critical for the spliceosome machinery, which carries out pre-mRNA splicing in eukaryotes[1][2]. However, RNU6-158P is a pseudogene, meaning it is a non-functional genetic relic that does not produce a functional RNA or protein product[3]. Pseudogenes like RNU6-158P are formed through genomic events such as retrotransposition or duplication but have lost their original biological function, often due to mutations or truncations[3]. U6 snRNA pseudogenes are numerous in vertebrate genomes, serving primarily as markers of genomic evolution and retrotransposition activity rather than active molecular roles[3]. This entry is not a receptor, enzyme, transporter, or otherwise considered a therapeutic target. No drugs, disease associations, biological functions, or mechanisms of action are attributed to this pseudogene. There are no known biomarker or safety concerns, as it is not an active molecule. Note: This entry is typically excluded from therapeutic or functional target lists and should not be considered a druggable or functional target.

Other names
RNU6-158PRNA, U6 snRNA pseudogene 158U6-158P

Beyond the preview

Go deeper on RNA, U6 small nuclear 158, pseudogene (RNU6-158P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 158, pseudogene (RNU6-158P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call